What is multiple myeloma?

Multiple myeloma is a type of blood cancer that attacks plasma cells in the bone marrow. This condition represents approximately one percent of all cancers, with approximately two percent of cancer deaths attributed to multiple myeloma. As with other cancer, this condition is not cure, but it can be treated, while the patient's prognosis varies depending on the stage at what stage the cancer is caught. Patients with multiple myeloma usually require careful monitoring in an effort to prevent the condition.

Plasma cells are extremely important because they generate antibodies for the immune system. In a healthy individual, there are about five percent of the cells in the bone bars of plasma cells; In a patient with multiple myeloma, this number may double, causing very serious health problems. Pusmatic cells can lead to anemia and also cause lesions in bones that are prone to breaking. Multiple myeloma also normally causes tumors.

Symptoms of this state MOHou be initially gentle. Bone pain is often the first sign, along with fatigue. If the condition is ill, patients may cause neurological problems due to increased calcium in their blood, which is caused by the dissolution of the bone. It is also common to see abnormal blood proteins when patients are tested, and the condition often causes kidney problems.

You can also hear this condition called myeloma of plasma cells, mm (for multiple myeloma) or Kahler's disease. In all cases, doctors have different treatment recommendations depending on the patient. For example, in cases where patients are asymptomatic, doctors may decide to simply monitor them. In patients with active problems related to multiple myeloma, various drugs may be prescribed to treat problems such as bone thinning and kidney failure. Integral myeloma can be used to use arsenal of treatment, including naRing, chemotherapy, stem cell transplantation, thalidomide, bortezomide and lenalidomide.

men and people of black ancestors tend to get more myeloma more than others. Unfortunately, for many patients, the condition is characterized by relapse. The cause of the initial mutation, which triggers multiple myeloma, is now known, although scientists are trying to learn more about this and other cancers to prevent and better treatment.